OBJECTIVE: To examine the impact of sleep duration on lung function and asthma symptoms in adolescents. METHODS:Ten adolescents with asthma (60% female, 60% Caucasian, mean age = 13.7 years, range 12-17) completed a 3-week randomized, cross-over sleep manipulation protocol. Following a week of self-selected sleep duration, adolescents were randomized to a five-night deficient sleep opportunity (6.5 hr in bed) or a healthy sleep opportunity (10 hr in bed) obtained by systematically changing bedtimes. Wake time remained consistent across all 3 weeks (including weekends). Daily reports of sleep patterns and asthma symptoms, actigraphy, and daily peak expiratory flow rates (PEFR), as well as weekly spirometry and exhaled nitric oxide were collected. RESULTS: Participants averaged 3.2 hr less sleep (P < 0.001) per night in the short sleep condition versus the long sleep condition. Further, they had an 8.4% decrease overnight in PEFR (P = 0.007), and reported more asthma symptoms interfering with activities in the past 24 hr (P = 0.02) in the short sleep condition than the long sleep condition. No significant differences between experimental weeks were found for weekly spirometry or exhaled nitric oxide. CONCLUSIONS: This pilot study demonstrated the feasibility of a cross-over sleep manipulation protocol in adolescents with asthma. Since overnight decrease in PEFR is a marker of nocturnal asthma, and has been associated with the severity of daytime airflow limitation, these early-stage results suggest that shortened sleep duration may exacerbate adolescent asthma and associated functional impairments.
RCT Entities:
OBJECTIVE: To examine the impact of sleep duration on lung function and asthma symptoms in adolescents. METHODS: Ten adolescents with asthma (60% female, 60% Caucasian, mean age = 13.7 years, range 12-17) completed a 3-week randomized, cross-over sleep manipulation protocol. Following a week of self-selected sleep duration, adolescents were randomized to a five-night deficient sleep opportunity (6.5 hr in bed) or a healthy sleep opportunity (10 hr in bed) obtained by systematically changing bedtimes. Wake time remained consistent across all 3 weeks (including weekends). Daily reports of sleep patterns and asthma symptoms, actigraphy, and daily peak expiratory flow rates (PEFR), as well as weekly spirometry and exhaled nitric oxide were collected. RESULTS:Participants averaged 3.2 hr less sleep (P < 0.001) per night in the short sleep condition versus the long sleep condition. Further, they had an 8.4% decrease overnight in PEFR (P = 0.007), and reported more asthma symptoms interfering with activities in the past 24 hr (P = 0.02) in the short sleep condition than the long sleep condition. No significant differences between experimental weeks were found for weekly spirometry or exhaled nitric oxide. CONCLUSIONS: This pilot study demonstrated the feasibility of a cross-over sleep manipulation protocol in adolescents with asthma. Since overnight decrease in PEFR is a marker of nocturnal asthma, and has been associated with the severity of daytime airflow limitation, these early-stage results suggest that shortened sleep duration may exacerbate adolescent asthma and associated functional impairments.
Authors: Danice K Eaton; Lela R McKnight-Eily; Richard Lowry; Geraldine S Perry; Letitia Presley-Cantrell; Janet B Croft Journal: J Adolesc Health Date: 2010-01-03 Impact factor: 5.012
Authors: Nicole Lamond; Sarah M Jay; Jillian Dorrian; Sally A Ferguson; Christopher Jones; Drew Dawson Journal: J Sleep Res Date: 2007-03 Impact factor: 3.981
Authors: Janet M Mullington; Norah S Simpson; Hans K Meier-Ewert; Monika Haack Journal: Best Pract Res Clin Endocrinol Metab Date: 2010-10 Impact factor: 4.690
Authors: Sarah M Jay; Nicole Lamond; Sally A Ferguson; Jillian Dorrian; Christopher B Jones; Drew Dawson Journal: Sleep Date: 2007-03 Impact factor: 5.849
Authors: Slobodanka Pejovic; Maria Basta; Alexandros N Vgontzas; Ilia Kritikou; Michele L Shaffer; Marina Tsaoussoglou; David Stiffler; Zacharias Stefanakis; Edward O Bixler; George P Chrousos Journal: Am J Physiol Endocrinol Metab Date: 2013-08-13 Impact factor: 4.310
Authors: Michelle M Perfect; Dean Beebe; Deborah Levine-Donnerstein; Sara S Frye; Grai P Bluez; Stuart F Quan Journal: Clin Pract Pediatr Psychol Date: 2016-06
Authors: Daphne Koinis-Mitchell; Sheryl J Kopel; Ronald Seifer; Monique LeBourgeois; Elizabeth L McQuaid; Cynthia A Esteban; Julie Boergers; Jack Nassau; Michael Farrow; Gregory K Fritz; Robert B Klein Journal: Sleep Health Date: 2017-04-11
Authors: Lisa J Meltzer; Dean W Beebe; Stephanie Jump; Kassie Flewelling; D Sundström; Michael White; Pamela L Zeitlin; Matthew J Strand Journal: Sleep Med Date: 2019-07-23 Impact factor: 4.842